使用物理化学性质的溶解制剂技术的合理选择
Kouya Kimoto1, Katsuhiko Yamamoto2,3, Toshiro Fukami4
1Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 2-26-1 Muraoka-Higashi, Fujisawa, Kanagawa 251-8555, Japan.
Chemical & pharmaceutical bulletin
|September 18, 2025
概括
选择药物配方技术,如无形固体分散 (ASD),基于脂质的配方 (LBF) 和纳米晶体 (NC),可以根据分子性质进行指导. 本研究确定了优化早期药物开发和加速时间表的关键指标.
科学领域:
- 制药科学 制药科学
- 药物运输 药物运输 药物运输
- 制定 发展 制定 发展
背景情况:
- 改善水溶性较差的药物的溶性对于口服小分子药物开发至关重要.
- 缺乏客观指标阻碍了选择合适的溶化制剂技术.
- 配方技术的早期选择会影响开发时间表.
研究的目的:
- 为无形固体分散 (ASD),循环素 (CD),基于脂质的配方 (LBF) 和纳米晶体 (NC) 技术建立选择指标.
- 为了利用分子特性来指导配方技术的选择.
- 通过提供合理的选择标准,加速药物开发的早期阶段.
主要方法:
- 在市场上销售的口服药物的分子特性 (分子量,点 (Tm),Log P,极地表面积 (PSA)) 的分析.
- 使用单属性和多属性地块进行数据可视化.
- 开发一个组合的属性图 (Tm和规范的Log P/PSA) 来确定最佳的配方范围.
主要成果:
- 单属性地块显示了分子性质的频率分布.
- 一个多个属性的地块确定了ASD,LBF和NC技术的最佳选择范围.
- 根据分析的分子性质,发现循环德克斯 (CD) 技术在确定最佳范围之外.
结论:
- 分子性质分析为选择溶化配方技术提供了客观指标.
- 开发的指标可以指导ASD,LBF和NC在药物开发早期阶段的合理选择.
- 这种方法通过利用早期分子数据来促进加速开发时间表.
相关概念视频
Biopharmaceutical Factors Influencing Drug Product Design: Overview
234
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
234
Bioavailability Enhancement: Drug Solubility Enhancement
223
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
223
Factors Influencing Drug Absorption: Pharmaceutical Parameters
404
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
404
Factors Influencing Drug Absorption: Physicochemical Parameters
820
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
820
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
153
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
153
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
3.1K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
3.1K


